CRDF
Cardiff Oncology Inc
1.30$
-1.5%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -3.7% | -1.0% | +2.9% | -3.8% | -5.0% | +137.5% | +0.4% | +115.7% | -54.9% | -0.9% | -121.3% | – | |
| – | -4.8% | +23.7% | +4.9% | +6.3% | -3.9% | +13.4% | +23.3% | -17.8% | -8.9% | +31.6% | -44.6% | – | |
| – | +36.0% | -13.7% | +15.8% | -85.5% | +87.1% | -315.9% | – | -130.0% | – | – | – | – | |
| – | -97.5% | +900.0% | -100.0% | – | – | – | – | -30.8% | -100.0% | – | – | – | |
| – | +254.9% | -65.8% | +202.3% | -167.3% | – | -423.3% | -65.8% | – | +5.8% | -69.7% | +276.7% | – | |
| – | +100.0% | – | – | +0.0% | – | – | – | – | – | – | – | – | |
| – | – | +791.7% | +1,823.4% | +260.9% | +495.0% | -100.0% | -100.0% | – | +10,112.0% | -95.9% | +41.9% | – | |
| – | – | -146.7% | – | -282.1% | – | -171.2% | – | – | – | -221.7% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.